Association Between US Drug Price and Measures of Efficacy for Oncology Drugs Approved by the US Food and Drug Administration From 2015 to 2020-Reference-Cited by-同舟云学术

Association Between US Drug Price and Measures of Efficacy for Oncology Drugs Approved by the US Food and Drug Administration From 2015 to 2020

Published:2022-12-01 Issue:12 Volume:182 Page:1319
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Miljković Miloš D.¹,Tuia Jordan E.²,Olivier Timothée²³,Haslam Alyson²,Prasad Vinay²⁴

Affiliation:

1. Cartesian Therapeutics, Gaithersburg, Maryland

2. Department of Epidemiology and Biostatistics, University of California, San Francisco

3. Department of Oncology, Geneva University Hospital, Geneva, Switzerland

4. Department of Medicine, University of California, San Francisco

Abstract

This cross-sectional study estimates all US Food and Drug Administration anticancer approvals in recent years and evaluates if an association exists between their cost and efficacy.

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2798197/jamainternal_miljkovi_2022_ld_220035_1670009048.42912.pdf

Reference6 articles.

1. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study.;Fitzmaurice;JAMA Oncol,2019

2. The high price of anticancer drugs: origins, implications, barriers, solutions.;Prasad;Nat Rev Clin Oncol,2017

3. Pricing in the market for anticancer drugs.;Howard;J Econ Perspect,2015

4. The strength of association between surrogate end points and survival in oncology: a systematic review of trial-level meta-analyses.;Prasad;JAMA Intern Med,2015

5. Five years of cancer drug approvals: innovation, efficacy, and costs.;Mailankody;JAMA Oncol,2015

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can Machine Learning Overcome the 95% Failure Rate and Reality that Only 30% of Approved Cancer Drugs Meaningfully Extend Patient Survival?;Journal of Medicinal Chemistry;2024-09-10

2. [Translated article] Characteristics, clinical benefit, and reimbursement of new authorisations for oncohaematology drugs in Spain between 2017 and 2020;Farmacia Hospitalaria;2024-07

3. Association between oral targeted cancer drug net health benefit, uptake, and spending;JNCI: Journal of the National Cancer Institute;2024-05-15

4. Profits over care? An analysis of the relationship between corporate capitalism in the healthcare industry and cancer mortality in the United States;Social Science & Medicine;2024-05

5. The Lancet Breast Cancer Commission;The Lancet;2024-05